|
Inverness Medical Innovations |
|
|
51 Sawyer Road, Suite 200
Waltham, MA 02453-3448 USA
phone:(781) 647-3900
fax:(781) 647 3939
|
|
| Symbol |
IMA |
| Exchange |
NYSE |
| Founded |
0 |
| Employees |
|
|
|
| www.invernessmedical.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Medical diagnostic testing and health management |
|
| Management |
| Ron Zwanziger, Chairman and CEO; David Scott, Chief Scientific Officer; Jerry McAleer, Vice President, Research & Development, Vice President; David Toohey, President, Europe & Middle East; John Yonkin, President, Inverness Medical Innovations North America; |
| |
|
|
|
|
|
|
|
| Keywords |
| chronic, cardiology, women�s health, infectious disease, oncology |
|
|
|
| Description |
|
Inverness Medical Innovations, Inc. (NYSE: IMA) is at the forefront of the convergence between medical diagnostic testing and health management. IMA is a major global developer, manufacturer and marketer of advanced, pioneering professional and consumer medical diagnostic products, as well as a leader in specialized health management services including wellness, disease management, oncology and women and children's health. |
|
| Technology / Differentiation |
| People are at the heart of our achievements. Indeed, it is the exceptional knowledge and experience of our research staff that underpins our ongoing R&D programmes. More than 200 experienced researchers are employed in our R & D facilities. The combined experience of the R&D staff represents over 900 years in the field of medical diagnostics. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
